World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
31515
World Ranking
15928
National Ranking
670

Andrea Bezjak publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrea Bezjak sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 479 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andrea Bezjak D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrea Bezjak sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andrea Bezjak is affiliated with the Princess Margaret Cancer Centre in Canada. Their work primarily focuses on the field of Medicine, with a significant emphasis on several subfields including Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Radiation, and Public Health, Environmental and Occupational Health.

Their research topics cover a range of areas related to lung cancer and advanced radiotherapy techniques. These include:

  • Lung Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Research Studies
  • Advances in Oncology and Radiotherapy
  • Neuroendocrine Tumor Research Advances

Andrea Bezjak has published extensively, with notable recent papers such as:

  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement (2020) in Radiotherapy and Oncology
  • Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement (2020) in International Journal of Radiation Oncology*Biology*Physics
  • Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET) (2024) in International Journal of Radiation Oncology*Biology*Physics
  • Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease (2024) in JAMA Oncology
  • Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial (2024) in International Journal of Radiation Oncology*Biology*Physics

The frequent co-authors collaborating with Andrea Bezjak include Meredith Giuliani, Benjamin H. Lok, A. Sun, Andrew Hope, and Srinivas Raman.

Publishing regularly in various academic venues, Andrea Bezjak's work appears most often in the following journals:

  • International Journal of Radiation Oncology*Biology*Physics
  • Radiotherapy and Oncology
  • Journal of Thoracic Oncology
  • Journal of Cancer Education
  • JAMA Oncology

Best Publications

  • Erlotinib in previously treated non-small-cell lung cancer.

    Frances A. Shepherd;José Rodrigues Pereira;Tudor Ciuleanu;Eng Huat Tan

  • Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

    Robert Timmerman;Rebecca Paulus;James Galvin;Jeffrey Michalski

  • Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases

    Jackson Sai-Yiu Wu;Rebecca Wong;Mary Johnston;Andrea Bezjak

  • Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial

    Christina A. Meyers;Jennifer A. Smith;Andrea Bezjak;Minesh P. Mehta

  • Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases

    Minesh P. Mehta;Patrick Rodrigus;C. H J Terhaard;Aroor Rao

  • Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

    Corinne Faivre-Finn;Michael Snee;Linda Ashcroft;Wiebke Appel

  • Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

    Andrea Bezjak;Dongsheng Tu;Lesley Seymour;Gary Clark

  • Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

    Andrea Bezjak;Rebecca Paulus;Laurie E. Gaspar;Robert D. Timmerman

  • Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

    Ralph M. Meyer;Mary K. Gospodarowicz;Joseph M. Connors;Robert G. Pearcey

  • Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position.

    Thomas G. Purdie;Jean Pierre Bissonnette;Kevin Franks;Andrea Bezjak

  • A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy. A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial

    F. A. Shepherd;J. Pereira;T. E. Ciuleanu;E. H. Tan

  • Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer.

    Frances A. Shepherd;Giuseppe Giaccone;Lesley Seymour;Channa Debruyne

  • Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

    Feng-Ming Spring Kong;Timothy Ritter;Douglas J Quint;Suresh Senan

  • Interpreting clinically significant changes in patient-reported outcomes.

    Jolie Ringash;Brian O'Sullivan;Andrea Bezjak;Donald A. Redelmeier

  • Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review

    Alysa Fairchild;Kristin Harris;Elizabeth Barnes;Rebecca Wong

  • The Management of Thymoma: A Systematic Review and Practice Guideline

    Conrad B. Falkson;Andrea Bezjak;Gail Darling;Richard Gregg;Richard Gregg

  • Function and Health Status Outcomes in a Randomized Trial Comparing Preoperative and Postoperative Radiotherapy in Extremity Soft Tissue Sarcoma

    Aileen M. Davis;B. O'Sullivan;R. S. Bell;R. Turcotte

  • Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome

    Richard W Tsang;Mary K Gospodarowicz;Melania Pintilie;Andrea Bezjak

  • Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

    David Osoba;Andrea Bezjak;Michael Brundage;Benny Zee

  • Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma

    Marc de Perrot;Ronald Feld;B.C. John Cho;Andrea Bezjak

Frequent Co-Authors

Frances A. Shepherd
Frances A. Shepherd Princess Margaret Cancer Centre
David A. Jaffray
David A. Jaffray The University of Texas MD Anderson Cancer Center
Natasha B. Leighl
Natasha B. Leighl Princess Margaret Cancer Centre
Shaf Keshavjee
Shaf Keshavjee University Health Network
Robert Timmerman
Robert Timmerman The University of Texas Southwestern Medical Center
Laura A. Dawson
Laura A. Dawson Princess Margaret Cancer Centre
Edward Chow
Edward Chow Sunnybrook Health Science Centre
Gerald M. Devins
Gerald M. Devins Princess Margaret Cancer Centre
Marc de Perrot
Marc de Perrot University of Toronto
Geoffrey Liu
Geoffrey Liu Princess Margaret Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to diverse career paths, many of which can be supported by flexible online programs. For registered nurses seeking to advance their careers, rn to np bridge programs offer a streamlined way to progress from ADN to MSN and become a nurse practitioner.

For those passionate about nutrition and its impact on health, the best online nutrition programs provide the foundation needed for roles in dietetics, public health, or private practice.

If you are interested in healthcare leadership and hospital administration, online mha programs accredited by CAHME can help you gain essential management skills with the convenience of distance learning.

Additionally, many nurses are looking for online degree pathways with minimal in-person requirements. The rn to bsn with no clinicals programs can help working nurses earn their BSN while managing other life commitments.

These online options make it easier than ever to take the next step toward a fulfilling healthcare career, no matter your starting point.

Best Scientists Citing Andrea Bezjak

Trending Scientists

Recently Published Articles